Cholesterol DrugsVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Combo Therapies to Lower Cholesterol Don't Work
Posted on 09/02/2009, 14:00
By -- Dennis Thompson
Review shows evidence doesn't support using other treatments with statins
WEDNESDAY, Sept. 2 (HealthDay News) -- Despite their popularity, so-called "combination therapies" may not be the most effective treatment for high cholesterol, Canadian researchers report.
In their review, the scientists analyzed data from 102 studies that tested combination therapies involving ezetimibe, niacin, bile acid sequestrants and omega-3 fatty acids. They concluded that there is little evidence to support the widespread use of combination therapies to lower cholesterol.
The results of this comprehensive review of clinical studies are important, as lowering cholesterol has been shown to decrease the risk of heart attack and stroke, and more than 35 million Canadians and Americans are prescribed cholesterol-lowering drugs each year, according to a news release from the Ottawa Hospital Research Institute.
In the new study, stroke specialist Dr. Mukul Sharma and colleagues from the Ottawa Hospital Research Institute and the University of Ottawa looked for evidence that supported the use of combination therapies vs. high-dose statin therapy.
Although statins are the most commonly used class of cholesterol-lowering drugs, some people don't respond to the standard dose. For these people, statins are increasingly being prescribed at higher doses or in combination with other types of drugs, according to the report published online Sept. 1 in the Annals of Internal Medicine.
"Our review shows that so far, there is not enough evidence to support the widespread use of combination therapies over high-dose statin therapy," Sharma said in the news release. "For most patients who don't respond to a low dose of statin, it would make sense to try a higher dose of statin before trying a combination therapy. If the high-dose statin does not work or is not well-tolerated, or if there are other special circumstances, a combination therapy may be a good option, but until more research is done, this is not recommended for most patients."
More information
Learn more about high blood cholesterol from the U.S. National Heart, Lung, and Blood Institute.
SOURCE: Ottawa Hospital Research Institute, news release, Aug. 31, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Babies in the Womb May Already Be Learning Language
Some Doctors Prescribe Antibiotics Because Parents Want Them
What Kids Wear Could Determine How Much Exercise They Get
Few College Students Have Received the H1N1 Vaccine
Night Lights Could Lead to Depression
Cervarix Has Been Approved by the FDA
The FDA Is Studying the Effects of Lasik Surgery
Painkillers Can Dull the Effects of Childhood Vaccines
Childbirth May Becoming More Complicated
Botox Sponges Might Help Nose Allergies
The FDA Advises on How to Properly Dispose of Medicine
A French Study Shows Cell Phones Do Not Affect Humans
MRIs May Lead to More Back Surgery
Your More Likely to Wash Your Hands If Someone's Watching

Comments (0):
Be the first to comment on this article.
Post a comment